The IKK/NF-κB pathway

Critical Care Medicine

Volumn 30, Issue 1 SUPPL. B, 2002, Pages

  Senftleben, Uwe ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; PROTEIN P50; PROTEIN P52; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE CONTROL; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0036162459     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201001-00003     Document Type: Conference Paper

References (124)

1. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism
2. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
3. Function and activation of NF-kappa B in the immune system
4. Structure, regulation and function of NF-kappa B
5. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation
6. The beginning of the end: I kappa B kinase (IKK) and NF-kappa B activation
7. NF-kappa B and rel proteins: Evolutionarily conserved mediators of immune responses
8. NF-kappa-B and rel proteins in innate immunity
9. Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice
10. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction
11. The precursor of NF-kappa B p50 has I kappa B-like functions
12. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B
13. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
14. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105: Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation
15. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation
16. The NF-kappa B, and I kappa B proteins: New discoveries and insights
17. Nuclear localization of I kappa B alpha promotes active transport of NF-kappaB from the nucleus to the cytoplasm
18. Phosphorylation meets ubiquitination: The control of NF-κB activity
19. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
20. Karin M Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B
21. A cytokine-responsive IkappaB kinase that activates the transkription factor NFkappaB
22. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IkappaB phosphorylation and NFkappaB activation
23. IKK-1 and IKK-2: Cytokine-activated I kappa B kinases essential for NF-kappa B activation
24. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
25. IKK-gamma is an essential regulatory subunit of the I kappa B kinase complex
26. Complementation cloning of NEMO, a component of the I kappa B kinase complex essential for NF-kappa B activation
27. Direct phosphorylation of IkappaB by IKKalpha and IKK-beta: Discrimination between free and NFkappaB-bound substrate
28. Positive and negative regulation of I kappa B kinase activity through IKK beta subunit phosphorylation
29. Complete reconstitution of human Ikappa b kinase (Ikk) complex in yeast
30. Activators and target genes of rel/ NF-kappaB transcription factors
31. The IKK beta subunit of I kappa B kinase (IKK) is essential for nuclear factor kappa B activation and prevention of apoptosis
32. Severe liver degeneration in mice lacking the I kappa B kinase 2 gene
33. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice
34. Limb and skin abnormalities in mice lacking IKK alpha
35. Abnormal morphogenesis but intact IKK activation in mice lacking the IKK alpha subunit of I kappa B kinase
36. Activation by IKKalpha of a second, evolutionary, conserved, NF-kappa B signaling pathway
37. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome
38. Phosphorylation meets ubiquitination: The control of NF-κB activity
39. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
40. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser- 176
41. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100
42. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase
43. IKKbeta is essential for protecting T cells from TN-Falpha-induced apoptosis
44. IkappaB kinase alpha is essential for mature B cell development and function
45. Expression of RelB is required for the development of thymic medulla and dentritic cells
46. Mice lacking the c-Rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
47. Targeted disruption of the p50 subunit of NF-kappaB leads to multifcal defects in immune responses
48. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappaB/Rel family
49. p50-NF-kappa B complexes partially compensate for the absence of relB: Severely increased pathology in p50(-/-)relB(-/-) double-knockout mice
50. Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice
51. NF-kappa B RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
52. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
53. Failure of lymphopoiesis after adoptive transfer of NF-kappa B-deficient fetal liver cells
54. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
55. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappa B1) but expressing p50
56. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects
57. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappaB
58. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
59. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment
60. IKK1-deficient mice exhibit abnormal development of skin and skeleton
61. IKKalpha controls formation of the epidermis independently of NF-kappaB
62. Severe liver degeneration and lack of NF-kappB activation in NEMO/IKKgamma-deficient mice
63. Female mice heterozygous for IKK-gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder Incontinentia Pigmenti
64. JNK2 and IKK beta are required for activating the innate response to viral infection
65. NEMO/IKK gamma-deficient mice model incontinentia pigmenti
66. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti
67. Requirement for NF-kappa B in osteoclast and B-cell development
68. Constitutive NF-kappaB activation, enhanced granulopoiesis, and neonatal lethality in I-kappaBalpha-deficient mice
69. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice
70. Multifocal defects in immune responses in RelB-deficient mice
71. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex
72. Regulation of immune responses by NF-kappa B/Rel transcription factors
73. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
74. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
75. 5′-flanking region surrounding a human cytosolic phospholipase A2 gene
76. Mechanisms of transcriptional activation of lipopolysaccharide binding protein (LBP)
77. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
78. The role of nuclear factor-kappa B in cytokine gene regulation
79. NF-kappa B, cooperativity between C/EBP, Baldwin AS Jr Distinct mechanisms for regulation of the interleukin-8 gene involve synergism
80. IL-6 and NF-IL6 in acute-phase response and viral infection
81. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha
82. Promoter of the human NF-kappa B p50/ p105 gene Regulation by NF-kappa B subunits and by c-REL
83. Regulation of an essential innate immune response by the p50 subunit of NF-kappa B
84. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers
85. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 anal IL-4 suppress cytokine synthesis by different mechanisms
86. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
87. The role of interleukin-1 in disease
88. Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis
89. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation
90. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
91. An essential role for nuclear factor kappa B in promoting double positive thymocyte apoptosis
92. Evolving concepts in the pathogenesis of postinjury multiple organ failure
93. NF-kappaB, reoxigenation Differential activation of transcription factors AP-1, Baeuerle PA The genomic response of tumor cells to hypoxia
94. Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia
95. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart
96. Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes
97. Redox regulation of NF-kappa B activation
98. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo
99. Hyperglycemia-induced activation of nuclear factor kappaB in vascular transcription smooth muscle cells
100. Activation of human macrophages by mechanical ventilation in vitro
101. Improved blood substitute: Evaluation of its effects on human endothelial cells
102. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons
103. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression
104. Oxygen-derived free radicals in postischemic tissue injury
105. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
106. Is NF-kappaB the sensor of oxidative stress?
107. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation
108. Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS
109. Early activation of pulmonary nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis
110. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids
111. Tissue factor expression in vital organs during murine traumatic shock: Role of transcription factors AP-1 and NF-kappaB
112. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome
113. Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction
114. Role of NFkappaB in the mortality of sepsis
115. Increased nuclear factor kappa B activation in critically ill patients who die
116. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis
117. Nuclear factor kappaB activation in acute appendicitis: A molecular marker for extent of disease?
118. Oxidative stress and NF-kappaB activation: Correlation in patients following allogeneic bone marrow transplantation
119. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome
120. Transcription factor NF kappa B expression and postsurgical organ dysfunction
121. Early activation of IKKbeta during in vivo myocardial ischemia
122. C/EBP beta regulation of the tumor necrosis factor alpha gene
123. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8